A Phase 3b Open-label Study Evaluating the Safety of Elexacaftor/Tezacaftor/Ivacaftor Combination Therapy in Cystic Fibrosis Subjects - VBX19-445-115

Project Details

Status	Finished
Effective start/end date	26/09/19 → 25/09/20